欧盟评估布氏乳杆菌NCIMB 30139作为所有动物饲料添加剂的授权更新申诶�/h1>

时间�?023-12-22 11:37 来源：食品伙伴网 作者： 泽夕

核心提示�?023�?2�?0日，欧盟食品安全局（EFSA）发布消息，欧盟食品安全局发布关于布氏乳杆菌NCIMB 30139作为所有动物饲料添加剂的授权更新申请的评估、�/div>

　　 食品伙伴网讯2023�?2�?0日， 欧盟食品安全局＇�a href='//www.sqrdapp.com/news/tag_10.html' class='zdbq' title='EFSA相关食品资讯' target='_blank'>EFSA）发布消息，欧盟食品安全局发布关于布氏 乳杆菋�/a>NCIMB 30139作为所月�a href='//www.sqrdapp.com/news/tag_4566.html' class='zdbq' title='动物相关食品资讯' target='_blank'>动物 饲料添加剁�/a>的授权更新申请的评估�

　　经过评估，专家小组得出结论，该添加剂在授权使用条件下对所有动物物种、消费者和环境都是安全的。在授权更新的情况下，无需评估添加剂的功效。部分原文报道如下：

　　Following a request from the European Commission, EFSA was asked to deliver a scientific opinion on the assessment of the application for renewal of Lentilactobacillus buchneri (formerly Lactobacillus buchneri) NCIMB 30139 as a technological additive for use in easy to ensile fresh material for all animal species. The applicant has provided evidence that the additive currently on the market complies with the existing co nditions of authorisation. There is no new evidence that would lead the FEEDAP Panel to reco nsider its previous conclusions. Thus, the Panel co ncludes that the additive remains safe for all animal species, co nsumer and the enviro nment under the authorised co nditions of use. Regarding user safety, the additive should be co nsidered as a respiratory sensitiser. The additive is not skin irritant, but no co nclusions can be drawn on the skin sensitisation or eye irritation potential of the additive. There is no need for assessing the efficacy of the additive in the co ntext of the renewal of the authorisation.

　　 本文由食品伙伴网食品资讯中心编辑，有任何疑问，请联系news@www.sqrdapp.com、�/span>

相关政策解读

欧盟食品快速预警系统知多少

日期９�a href="//www.sqrdapp.com/news/2023-12-22.html">2023-12-22

地区９�/font>欧盟国外
行业９�/font>添加剂配斘�/font>乳业进出叢�/font>
标签９�/font>动物乳杆菋�/font>饲料添加剁�/font>欧盟食品安全局EFSA
科普９�/font>动物乳杆菋�/font>饲料添加剁�/font>欧盟食品安全局EFSA

分享:

食品商城，食品产业链内部交易、�/a>

• 下一篇：海关总署动植物检疫司关于恢复台湾地区石斑鱼输入大陆的通知（动植检函�?023�?0号）

[ 食品资讯搜索] [ 加入收藏] [ 告诉好友] [ 打印本文] [ 关闭窗口]

欧盟食品安全局相关食品资讯

? 欧盟食品安全局就锰的安全摄入量发表科学意见	? 欧盟食品安全局发布2022年传染性海绵状脑病监测
? 欧盟评估α-半乳糖苷酶和内切-1,4-β-葡聚糖酶